Impact of Pulmonary Follow-up After Stem Cell Graft

Impact of Systematic Pulmonary Follow-up After Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation is the only possible treatment for many malignant and non-malignant hemopathies. The graft-versus-host immunological reaction (GvH) is a frequent and sometimes serious complication. The objective is to study whether a systematic and early follow-up by a lung specialist of allografted patients would allow an earlier diagnosis of GvH with pulmonary complications.

Inclusion Criteria:

• 18 years of age or older
• patients with a hematopoietic stem cell transplantation

Exclusion Criteria:

• Death within 100 days post-surgery